Brentwood Biomedical Research Institute Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2014
NCT02676375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

bupropion (wellbutrin) (1 trial)

nicotine (nicorette) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Schizophrenia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2